Search by Drug Name or NDC

    NDC 65219-0287-30 Gadobutrol 604.72 mg/mL Details

    Gadobutrol 604.72 mg/mL

    Gadobutrol is a INTRAVENOUS INJECTION in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Fresenius Kabi USA, LLC. The primary component is GADOBUTROL.

    Product Information

    NDC 65219-0287
    Product ID 65219-287_54027cd5-9739-4e3a-8485-ff2928426ebc
    Associated GPIs
    GCN Sequence Number 054612
    GCN Sequence Number Description gadobutrol VIAL 1 MMOL/ML INTRAVEN
    HIC3 Z9D
    HIC3 Description DIAGNOSTIC PREPARATIONS,MISCELLANEOUS
    GCN 22586
    HICL Sequence Number 021847
    HICL Sequence Number Description GADOBUTROL
    Brand/Generic Generic
    Proprietary Name Gadobutrol
    Proprietary Name Suffix n/a
    Non-Proprietary Name Gadobutrol
    Product Type HUMAN PRESCRIPTION DRUG
    Dosage Form INJECTION
    Route INTRAVENOUS
    Active Ingredient Strength 604.72
    Active Ingredient Units mg/mL
    Substance Name GADOBUTROL
    Labeler Name Fresenius Kabi USA, LLC
    Pharmaceutical Class Gadolinium-based Contrast Agent [EPC], Magnetic Resonance Contrast Activity [MoA]
    DEA Schedule n/a
    Marketing Category ANDA
    Application Number ANDA216081
    Listing Certified Through 2024-12-31

    Package

    NDC 65219-0287-30 (65219028730)

    NDC Package Code 65219-287-30
    Billing NDC 65219028730
    Package 10 BOTTLE in 1 CARTON (65219-287-30) / 30 mL in 1 BOTTLE (65219-287-10)
    Marketing Start Date 2023-10-01
    NDC Exclude Flag N
    Pricing Information N/A